Lotus Pharm vs SCI: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and SCI (4119) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ SCI

0%+226%-47%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYSCIYoY
Oct 2026NT$2.13 billion-22.5%NT$131 million+30.4%
Sep 2026NT$2.77 billion+128.0%NT$163.4 million+33.1%
Aug 2026NT$2.11 billion+81.7%NT$149 million+187.5%
Jul 2026NT$2.49 billion+3.9%NT$190.8 million+133.2%
Jun 2026NT$3.4 billion+225.5%NT$123.2 million+36.1%
May 2026NT$2.32 billion+105.8%NT$60.9 million-47.1%
Apr 2026NT$3.09 billion+19.9%NT$88.7 million-46.5%
Mar 2026NT$4.35 billion+173.6%NT$127.6 million-24.4%
Feb 2026NT$2.24 billion+131.5%NT$118.5 million+39.9%
Jan 2026NT$2.05 billion-5.5%NT$129.7 million+21.4%
Dec 2025NT$2.44 billion+66.9%NT$151.6 million+94.5%
Nov 2025NT$1.06 billion-0.2%NT$103.4 million-33.5%
Oct 2025NT$2.75 billion+46.0%NT$100.5 million-40.3%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16